Auro-Cefepime Injection

Auro-Cefepime Injection

S4
PDF Leaflet Revision Date: 23 August 2022

API: Cefepime | Company: Aurogen South Africa

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of infections caused by susceptible bacteria.

Dosage (summary)

Adults: 0.5-2 g IV/IM every 8-12 hours; adjust for renal impairment.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Safety in pregnancy and lactation not established.

Key Drug Interactions

  • Aminoglycosides
  • Vancomycin
  • Gentamicin

Contraindications

  • Hypersensitivity to cefepime or beta-lactams

Common side effects

  • Diarrhoea
  • Nausea
  • Headache
  • Dizziness

Counselling Points

  • Monitor for allergic reactions
  • Report severe diarrhea
  • Adjust dosage in renal impairment

Serious warnings

  • Risk of seizures in renal impairment
  • Pseudomembranous colitis
Important Disclaimer

The Auro-Cefepime Injection professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites